Skip to content

Discontinued — last reported Q1 '26

Net Income at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$1.65B+9.6%
Charles River Laboratories logo
Charles River LaboratoriesCRL
-$14.84M-158%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$43.17M+5.4%
TEC
Bio-TechneTECH
$51.05M+126%
Azenta logo
AzentaAZTA
-$160.8M-237%
Regenxbio logo
RegenxbioRGNX
-$90.05M-1,580%

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's net income?
Ginkgo Bioworks (DNA) reported net income of -$82.59M in Q1 2026.
How has Ginkgo Bioworks's net income changed year-over-year?
Ginkgo Bioworks's net income increased by 9.2% year-over-year, from -$90.96M to -$82.59M.
What is the long-term trend for Ginkgo Bioworks's net income?
Over 4 years (2021 to 2025), Ginkgo Bioworks's net income has grown at a -35.7% compound annual growth rate (CAGR), from -$1.83B to -$312.76M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.